Quidelortho Corp (QDEL) Stock Price, Quote & News

Company Profile

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, ant...

Industry: Medical Devices

Sector: Healthcare

Phone: 858 552 1100

Fax: 858 453 4338

Website: www.quidelortho.com

Address:

9975 Summers Ridge Road, San Diego, United States

BullYa Jan. 27 at 12:23 PM

$QDEL ✅ heading $31 again then 💨🛫

0 · Reply

BullYa Jan. 26 at 5:32 PM

$QDEL should be 32~35 at normal range. Loading it up, long term is looking good. 52-week high at $45’s.

0 · Reply

BillionerOfKing Jan. 22 at 12:04 PM

$QDEL Current Stock Price: $29.40 Contracts to trade: $30 QDEL Feb 20 2026 Call Entry: $1.44 Exit: $2.07 ROI: 44% Hold ~28 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

BullYa Jan. 21 at 8:44 PM

$QDEL ✅ buy the dip !

0 · Reply

Chickenstick1 Jan. 21 at 8:35 PM

$QDEL In buying today. The new entrant shorts are poised to get blasted out of their position come earnings. It doesn't take a lot of effort to do some channel checking.

0 · Reply

BullYa Jan. 21 at 7:54 PM

$QDEL last call ✅ $3.50 discount per share of the day ✅💨🛫

0 · Reply

BullYa Jan. 21 at 7:48 PM

$QDEL ✅ let’s get $31+ at eod

0 · Reply

goinbananas Jan. 21 at 7:06 PM

$QDEL no good reason for this harsh drop. Guessing someone wants to load up. Adding more! $ARKG $LABU

0 · Reply

AdamInvest Jan. 21 at 6:42 PM

$QDEL I know people that work here so I don’t know what the bulls seen😂

1 · Reply

BullYa Jan. 21 at 5:57 PM

$QDEL ✅ $30+ at eod possibly

0 · Reply

Strengthening the blood supply: Awareness, challenges and donor impact

Jan 21, 2026, 7:00 AM EST - 8 days ago

QuidelOrtho to Report Fourth Quarter and Full-Year 2025 Financial Results

Dec 18, 2025, 9:17 AM EST - 6 weeks ago

Innovating Diagnostics and What's Next

Dec 3, 2025, 3:43 PM EST - 2 months ago

QuidelOrtho Corporation (QDEL) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

Nov 24, 2025, 7:00 AM EST - 2 months ago

QuidelOrtho To Participate In Upcoming Investor Conferences

Nov 20, 2025, 9:00 AM EST - 2 months ago

The Power of Prevention: Detecting Diabetes Before It Strikes

Nov 6, 2025, 5:46 AM EST - 3 months ago

QuidelOrtho Corporation (QDEL) Q3 2025 Earnings Call Transcript

Nov 5, 2025, 4:05 PM EST - 3 months ago

QuidelOrtho Reports Third Quarter 2025 Financial Results

Nov 3, 2025, 7:00 AM EST - 3 months ago

QuidelOrtho Receives FDA 510(k) Clearance for VITROS™ Immunodiagnostic Products hs Troponin I Assay

Oct 23, 2025, 6:45 PM EDT - 3 months ago

Informatics Illuminated: Science Bytes Podcast Explores the Power Behind Smarter Diagnostics

Oct 22, 2025, 7:00 AM EDT - 3 months ago

QuidelOrtho to Report Third Quarter 2025 Financial Results

Oct 16, 2025, 8:30 PM EDT - 3 months ago

QuidelOrtho Showcases Leadership in Transfusion Medicine at AABB 2025

Sep 25, 2025, 9:00 AM EDT - 4 months ago

Through Shades of Illness: Science Bytes Podcast Discusses Why Testing Matters

Sep 22, 2025, 7:00 AM EDT - 4 months ago

QuidelOrtho Announces Availability of QUICKVUE™ Influenza + SARS Test for Professional Use

Aug 28, 2025, 7:30 AM EDT - 5 months ago

QuidelOrtho to Participate in the Baird 2025 Global Healthcare Conference

Aug 21, 2025, 4:30 PM EDT - 5 months ago

QuidelOrtho Completes Debt Refinancing

Aug 21, 2025, 9:00 AM EDT - 5 months ago

Science Bytes Podcast Explores How Diagnostics Can Help Protect Students and Communities

Aug 19, 2025, 4:05 PM EDT - 5 months ago

QuidelOrtho Welcomes Erich Wolff as Executive Vice President, Strategy & Corporate Development

Aug 13, 2025, 3:00 PM EDT - 6 months ago

QuidelOrtho Launches Certified Analyzer Program

Aug 6, 2025, 1:07 AM EDT - 6 months ago

QuidelOrtho Corporation (QDEL) Q2 2025 Earnings Call Transcript

Aug 5, 2025, 4:10 PM EDT - 6 months ago

QuidelOrtho Reports Second Quarter 2025 Financial Results

Jul 29, 2025, 5:00 PM EDT - 6 months ago

QuidelOrtho Recognized with Three Awards in 2025 IMV ServiceTrak™

Jul 24, 2025, 9:00 AM EDT - 6 months ago

Urgent Need for Early Detection in Drug Overdose Cases Highlighted in New Podcast

Jul 22, 2025, 4:30 PM EDT - 6 months ago

QuidelOrtho to Report Second Quarter 2025 Financial Results

Jul 17, 2025, 7:00 AM EDT - 7 months ago

Real Labs, Actual Decisions With Actionable Six Sigma Metrics

Jul 14, 2025, 7:00 AM EDT - 7 months ago

QUIDELORTHO AND BÜHLMANN LABORATORIES AG ANNOUNCE AVAILABILITY OF FECAL CALPROTECTIN (FCAL®) TURBO AND FECAL PANCREATIC ELASTASE (FPELA®) TURBO ASSAYS ON VITROS™ SYSTEMS AS A MICROTIP™ PARTNERSHIP ASSAY (MPA)

Jul 7, 2025, 7:00 AM EDT - 7 months ago

QuidelOrtho Strengthens Leadership Team With Appointments of Senior Vice Presidents for Global Quality and Clinical & Regulatory Affairs

Jun 3, 2025, 4:10 PM EDT - 8 months ago

QuidelOrtho Announces Strategy to Accelerate Growth in Molecular Diagnostics

May 22, 2025, 4:30 PM EDT - 9 months ago

QuidelOrtho to Participate in Upcoming Investor Conferences

May 12, 2025, 9:30 AM EDT - 9 months ago

QuidelOrtho: Stagnant Growth Means Best To Avoid (Rating Downgrade)

May 7, 2025, 7:56 PM EDT - 9 months ago

QuidelOrtho Corporation (QDEL) Q1 2025 Earnings Call Transcript

May 7, 2025, 4:05 PM EDT - 9 months ago

QuidelOrtho Reports First Quarter 2025 Financial Results

Apr 23, 2025, 4:30 PM EDT - 10 months ago

QuidelOrtho to Report First Quarter 2025 Financial Results

Mar 10, 2025, 9:00 AM EDT - 11 months ago

QuidelOrtho® Introduces Results Manager™ System

Feb 24, 2025, 7:00 AM EST - 1 year ago

QuidelOrtho to Participate in the 46th Annual Raymond James Institutional Investor Conference

Feb 12, 2025, 7:50 PM EST - 1 year ago

QuidelOrtho Corporation (QDEL) Q4 2024 Earnings Call Transcript

Feb 12, 2025, 4:05 PM EST - 1 year ago

QuidelOrtho Reports Fourth Quarter and Full-Year 2024 Financial Results

Jan 13, 2025, 9:00 AM EST - 1 year ago

QuidelOrtho Announces Preliminary Unaudited Revenue for Fourth Quarter 2024

Jan 7, 2025, 12:48 AM EST - 1 year ago

Kuehn Law Encourages Investors of QuidelOrtho Corporation to Contact Law Firm

Dec 31, 2024, 7:00 AM EST - 1 year ago

QuidelOrtho to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Dec 10, 2024, 7:00 AM EST - 1 year ago

QuidelOrtho Announces Appointment of Two Independent Directors to its Board

Nov 20, 2024, 3:08 PM EST - 1 year ago

Carlyle Sells QuidelOrtho Shares, Analyst Sees Overhang Lifted

Nov 20, 2024, 8:06 AM EST - 1 year ago

Powell Industries Reports Weak Sales, Joins Target, QuidelOrtho And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

TGT POWL

Nov 19, 2024, 9:05 PM EST - 1 year ago

QuidelOrtho Corporation Announces Pricing of Secondary Offering of Common Stock by the Carlyle Group

Nov 19, 2024, 4:54 PM EST - 1 year ago

QuidelOrtho Corporation Announces Secondary Offering of Common Stock by the Carlyle Group

Nov 11, 2024, 6:18 AM EST - 1 year ago

Top 4 Health Care Stocks That May Plunge This Quarter

AIRS NUVB PODD

Nov 7, 2024, 8:54 PM EST - 1 year ago

QuidelOrtho Corporation (QDEL) Q3 2024 Earnings Call Transcript

Nov 7, 2024, 4:05 PM EST - 1 year ago

QuidelOrtho Reports Third Quarter 2024 Financial Results

Oct 28, 2024, 7:00 AM EDT - 1 year ago

QuidelOrtho to Participate in Three Upcoming Investor Conferences

BullYa Jan. 27 at 12:23 PM

$QDEL ✅ heading $31 again then 💨🛫

0 · Reply

BullYa Jan. 26 at 5:32 PM

$QDEL should be 32~35 at normal range. Loading it up, long term is looking good. 52-week high at $45’s.

0 · Reply

BillionerOfKing Jan. 22 at 12:04 PM

0 · Reply

BullYa Jan. 21 at 8:44 PM

$QDEL ✅ buy the dip !

0 · Reply

Chickenstick1 Jan. 21 at 8:35 PM

$QDEL In buying today. The new entrant shorts are poised to get blasted out of their position come earnings. It doesn't take a lot of effort to do some channel checking.

0 · Reply

BullYa Jan. 21 at 7:54 PM

$QDEL last call ✅ $3.50 discount per share of the day ✅💨🛫

0 · Reply

BullYa Jan. 21 at 7:48 PM

$QDEL ✅ let’s get $31+ at eod

0 · Reply

goinbananas Jan. 21 at 7:06 PM

$QDEL no good reason for this harsh drop. Guessing someone wants to load up. Adding more! $ARKG $LABU

0 · Reply

AdamInvest Jan. 21 at 6:42 PM

$QDEL I know people that work here so I don’t know what the bulls seen😂

1 · Reply

BullYa Jan. 21 at 5:57 PM

$QDEL ✅ $30+ at eod possibly

0 · Reply

Staska Jan. 21 at 4:22 PM

$QDEL I hope it's not because of Q4 report date announcement today, are they idiots?! crazy flu season around the world! https://ir.quidelortho.com/news/news-release-details/2026/QuidelOrtho-to-Report-Fourth-Quarter-and-Full-Year-2025-Financial-Results/default.aspx

0 · Reply

Paardaam Jan. 21 at 4:12 PM

$QDEL what’s the news behind this crash ?

1 · Reply

StockBraker Jan. 21 at 3:53 PM

$QDEL stock price target raised to $35 from $31 at UBS on respiratory season https://www.investing.com/news/analyst-ratings/quidelortho-stock-price-target-raised-to-35-from-31-at-ubs-on-respiratory-season-93CH-4457281

0 · Reply

StockBraker Jan. 21 at 3:51 PM

$QDEL Anyone? anyone? Bueller?

0 · Reply

Rdeda Jan. 21 at 3:21 PM

$QDEL whats going on…. Who is selling

0 · Reply

edwardmitchell Jan. 21 at 3:20 PM

$QDEL news?

0 · Reply

Bazzzigar Jan. 19 at 2:28 PM

$QDEL BBNX

0 · Reply

Chickenstick1 Jan. 16 at 6:39 PM

$QDEL bad flu season usually leads to several huge quarters. I like this name on valuation alone, but, now, there is a catalyst. I feel inclined to buy into any weakness.

1 · Reply

goinbananas Jan. 15 at 10:52 PM

$QDEL moving along nicely, another 35% since 12/11/25 $ARKG $LABU $QQQ

0 · Reply

ZacksResearch Jan. 15 at 3:59 PM

Is $QDEL's growth potential enough to outweigh its dependency risks? 🤔 💰 QuidelOrtho has an average surprise of 33% over the last four quarters and gained 22.9% in the last six months. ⚠️ But, heavy reliance on respiratory testing and reimbursement risks loom large. Find out what QDEL's future holds here 👉 https://www.zacks.com/stock/news/2818195/reasons-to-retain-quidelortho-stock-in-your-portfolio-for-now?cid=sm-stocktwits-2-2818195-body-29088&ADID=SYND_STOCKTWITS_TWEET_2_2818195_BODY_29088

0 · Reply

ZacksResearch Jan. 15 at 2:59 PM

Hold your horses on selling $QDEL — this one still earns a spot in your portfolio (for now). 🧪📊 Decent Q3 2025 results and an expanding diagnostics portfolio are supporting near-term growth, even as respiratory dependence and payer-related risks linger. See the full risk/reward setup here 👉 https://www.zacks.com/stock/news/2818195/reasons-to-retain-quidelortho-stock-in-your-portfolio-for-now?cid=sm-stocktwits-2-2818195-teaser-29052&ADID=SYND_STOCKTWITS_TWEET_2_2818195_TEASER_29052

0 · Reply

Thelonius_Stonk Jan. 9 at 8:41 PM

$QDEL nice week

0 · Reply

Market Cap	1.82B
Revenue (ttm)	2.78B
Net Income (ttm)	-2.05B
EPS (ttm)	N/A
PE Ratio	11.91
Forward PE	10.96
Profit Margin	-73.74%
Debt to Equity Ratio	1.31

Volume	888,900
Avg Vol	1,001,360
Day's Range	N/A - N/A
Shares Out	67.93M
Stochastic %K	16%
Beta	0.59
Analysts	Sell
Price Target	$38.33